FDA is Going to Restrict or Eliminate Compounding Hormones?

This will effect many nuBirds (nuHealth patients)!

The FDA has said it will consider restricting or even eliminating cBHT based on a faulty research study. This is an existential threat for the compounding industry, and potentially a nightmare for the millions of Americans who rely on cBHT therapy. It will require an ambitious, long-term, and nationwide effort to stop it.

The Alliance for Pharmacy Compounding, with your help, is stepping up to protect your business and your patients. They’re planning a three-year, multi-pronged campaign to focus not on statistics, but on the human face of compounded hormone therapy: the patients it helps.

Check out this proof-of-concept video for a feel of the campaign’s tone:

APC is planning a nationwide electronic, print, and video effort targeted at the people who can make a difference. Please pledge if you can: https://a4pc.org.

This is more than a contribution. It’s an investment in the future of compounding practices and the ability to provide patients with the compounded hormones they need.